Therapeutic angiogenesis for ischemic syndromes

Israel Medical Association Journal

Volumn 2, Issue SUPPL. JULY, 2000, Pages 52-57

  Weisz, A ^a   Koren, B ^a   Fischer, L ^a   Lewis, B S ^a   Flugelman, M Y ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Atherosclerosis; Ischemic syndromes

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATHEROSCLEROSIS; BLOOD VESSEL; CELL CULTURE; CELL PROLIFERATION; COLLATERAL CIRCULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; MALE; RAT; WESTERN BLOTTING;

ADENOVIRIDAE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; COLLATERAL CIRCULATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FEMORAL ARTERY; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HINDLIMB; HUMANS; ISCHEMIA; LAC OPERON; LYMPHOKINES; MALE; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SAPHENOUS VEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033867589     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
2. Angiogenesis by gene therapy: A new horizon for myocardial revascularization?
3. Angiogenesis in ischemic heart disease
4. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
5. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
6. Mechanisms of angiogenesis
7. Regulators of angiogenesis
8. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
9. Functional upregulation of the endothelial growth factor receptor KDR by hypoxia
10. Vascular endothelial growth factor is a secreted angiogenic factor
11. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
12. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
13. Human gene therapy
14. Vascular applications of human gene therapy
15. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo
16. Efficient gene transfer into myocardium by direct injection of adenovirus vectors
17. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
18. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
19. High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system
20. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
21. Vascular gene therapy
22. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease
23. Therapeutic angiogenesis in ischemic limbs
24. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
25. Naked cDNA encoding secreted proteins for intra-arterial and intramuscular gene transfer vascular applications of human gene therapy
26. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
27. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
28. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene
29. Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia
30. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors
31. Adenovirus and adeno-associated mediated virus mediated gene transfer
32. Virus treatment questioned after gene therapy death
33. Researchers and regulators reflect on first gene therapy death